Journal
CANCER IMMUNOLOGY IMMUNOTHERAPY
Volume 70, Issue 7, Pages 1867-1876Publisher
SPRINGER
DOI: 10.1007/s00262-020-02798-z
Keywords
Lung cancer; Tumor microenvironment; Cytokines; Bronchoalveolar lavage fluid; Whole-blood serum
Categories
Funding
- University of Zurich
- EMDO Stiftung
- Department of Immunology, University Hospital Zurich
Ask authors/readers for more resources
Our study analyzed cytokines in bronchoalveolar lavage fluid (BALF) of lung cancer patients, finding significant differences compared to healthy individuals, but these differences were not statistically significant when compared to other lung diseases in multivariate analysis. Cytokine levels in BALF were close to the lower detection limit and showed minimal correlation with their levels in serum of the same individual.
Introduction Lung cancer is the leading cause of death by cancer. In recent years, immunotherapy with checkpoint inhibitors (ICI) emerged as a promising new therapeutic approach. However, a deeper understanding of the immunologic responses adjacent to the tumor known as tumor microenvironment (TME) is needed. Our study investigated TME of lung cancer by analyzing cytokines in bronchoalveolar lavage fluid (BALF). Materials and methods Between January 2018 and June 2019, 119 patients were prospectively enrolled in this study. For each cancer patient, levels of 16 cytokines (fractalkine, granulocyte-macrophage colony-stimulating factor (GM-CSF), interferon gamma (IFN-gamma), tumor necrosis factor alpha (TNF-alpha), and interleukins (IL): IL-1b, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-10, IL-12p70, IL-13, IL-17A, and IL-23) were measured in BALF and serum and compared to healthy individuals and patients with other lung diseases. Results There were several significant differences of cytokine levels of patients with lung cancer compared to healthy individuals. However, none of them remained in the multivariate analysis compared to other lung diseases in either BALF or serum. Furthermore, there were no significant differences between the groups in cell differentiation of either BALF or serum. Cytokine levels in BALF were generally near the lower detection limit and showed almost no correlation with their respective levels measured in serum of the same individual. Conclusions Cytokines in BALF and serum of lung cancer patients may indicate unspecific inflammation. BAL is not recommendable as a tool to investigate TME of lung cancer. Therefore, cytokines measured in BALF are probably not appropriate as predictors in patients treated with ICIs.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available